124 related articles for article (PubMed ID: 15074396)
1. Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease.
Tacke F; Schöffski P; Luedde T; Meier PN; Ganser A; Manns MP; Trautwein C
Scand J Gastroenterol; 2004 Mar; 39(3):259-66. PubMed ID: 15074396
[TBL] [Abstract][Full Text] [Related]
2. Reduced serum levels of immunoreactive erythropoietin in patients with cirrhosis and chronic anemia.
Siciliano M; Tomasello D; Milani A; Ricerca BM; Storti S; Rossi L
Hepatology; 1995 Oct; 22(4 Pt 1):1132-5. PubMed ID: 7557862
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a multifactorial control of serum erythropoietin concentration in liver disease.
Pirisi M; Fabris C; Falleti E; Soardo G; Toniutto P; Gonano F; Bartoli E
Clin Chim Acta; 1993 Oct; 219(1-2):47-55. PubMed ID: 8306463
[TBL] [Abstract][Full Text] [Related]
4. Plasma erythropoietin level in patients with cirrhosis and its relationship to the severity of cirrhosis and renal function.
Yang YY; Lin HC; Lee WC; Huang YT; Hou MC; Lee FY; Chang FY; Lee SD
J Gastroenterol Hepatol; 2003 Oct; 18(10):1156-61. PubMed ID: 12974902
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis.
Zimmermann HW; Seidler S; Gassler N; Nattermann J; Luedde T; Trautwein C; Tacke F
PLoS One; 2011; 6(6):e21381. PubMed ID: 21731723
[TBL] [Abstract][Full Text] [Related]
6. Plasma erythropoietin levels in anaemic and non-anaemic patients with chronic liver diseases.
Bruno CM; Neri S; Sciacca C; Bertino G; Di Prima P; Cilio D; Pellicano R; Caruso L; Cristaldi R
World J Gastroenterol; 2004 May; 10(9):1353-6. PubMed ID: 15112358
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between tumor necrosis factor alpha, interleukin-6 and erythropoietin in children's with chronic anemia and influence of recombinant human tumor necrosis factor alpha on erythropoietin gene expression].
Zhai XW; Wu Y; Gu XF; Lu FJ
Zhonghua Er Ke Za Zhi; 2004 Jan; 42(1):62-5. PubMed ID: 14990112
[TBL] [Abstract][Full Text] [Related]
8. Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers.
Ferrucci L; Guralnik JM; Bandinelli S; Semba RD; Lauretani F; Corsi A; Ruggiero C; Ershler WB; Longo DL
Br J Haematol; 2007 Mar; 136(6):849-55. PubMed ID: 17341272
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin mimics the acute phase response in critical illness.
Elliot JM; Virankabutra T; Jones S; Tanudsintum S; Lipkin G; Todd S; Bion J
Crit Care; 2003 Jun; 7(3):R35-40. PubMed ID: 12793888
[TBL] [Abstract][Full Text] [Related]
10. [Pattern of blood levels of erythropoietin and proinflammatory cytokines in patients with anemia of chronic disorders secondary to infection].
Poveda Gómez F; Camacho Siles J; Quevedo Morales E; Fernández Zamorano A; Codoceo Alquinta R; Arnalich Fernández F; Sempere Alcocer M
An Med Interna; 2001 Jun; 18(6):298-304. PubMed ID: 11503575
[TBL] [Abstract][Full Text] [Related]
11. Hepatic erythropoietin response in cirrhosis.
Risør LM; Fenger M; Olsen NV; Møller S
Scand J Clin Lab Invest; 2016; 76(3):234-9. PubMed ID: 26924722
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory markers and platelet aggregation tests as predictors of hemoglobin and endogenous erythropoietin levels in hemodialysis patients.
Borawski J; Pawlak K; Myśliwiec M
Nephron; 2002 Aug; 91(4):671-81. PubMed ID: 12138272
[TBL] [Abstract][Full Text] [Related]
13. Serum-soluble Fas and serum levels of erythropoietin in chronic kidney disease.
Góes MA; Dalboni MA; Manfredi SR; Cendoroglo MS; Batista MC; Canziani ME; Balakrishnan VS; Pereira BJ; Draibe SA; Cendoroglo M
Clin Nephrol; 2010 Jan; 73(1):7-13. PubMed ID: 20040346
[TBL] [Abstract][Full Text] [Related]
14. Decreased erythropoietin response in Plasmodium falciparum malaria-associated anaemia.
el Hassan AM; Saeed AM; Fandrey J; Jelkmann W
Eur J Haematol; 1997 Nov; 59(5):299-304. PubMed ID: 9414641
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.
van der Meer P; Voors AA; Lipsic E; Smilde TD; van Gilst WH; van Veldhuisen DJ
J Am Coll Cardiol; 2004 Jul; 44(1):63-7. PubMed ID: 15234408
[TBL] [Abstract][Full Text] [Related]
16. Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease.
Artunc F; Risler T
Nephrol Dial Transplant; 2007 Oct; 22(10):2900-8. PubMed ID: 17556407
[TBL] [Abstract][Full Text] [Related]
17. Ghrelin in chronic liver disease.
Tacke F; Brabant G; Kruck E; Horn R; Schöffski P; Hecker H; Manns MP; Trautwein C
J Hepatol; 2003 Apr; 38(4):447-54. PubMed ID: 12663236
[TBL] [Abstract][Full Text] [Related]
18. Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease.
Wagner M; Alam A; Zimmermann J; Rauh K; Koljaja-Batzner A; Raff U; Wanner C; Schramm L
Clin J Am Soc Nephrol; 2011 Jul; 6(7):1573-9. PubMed ID: 21734083
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin concentration in acute kidney injury is associated with insulin-like growth factor-binding protein-1.
Yamashita T; Noiri E; Hamasaki Y; Matsubara T; Ishii T; Yahagi N; Nangaku M; Doi K
Nephrology (Carlton); 2016 Aug; 21(8):693-9. PubMed ID: 26479890
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of endogenous erythropoietin in long-term outcome of patients with acute decompensated heart failure.
Nagai T; Nishimura K; Honma T; Higashiyama A; Sugano Y; Nakai M; Honda S; Iwakami N; Okada A; Kawakami S; Kanaya T; Asaumi Y; Aiba T; Nishida Y; Kubota Y; Sugiyama D; Okamura T; Noguchi T; Kusano K; Ogawa H; Yasuda S; Anzai T;
Eur J Heart Fail; 2016 Jul; 18(7):803-13. PubMed ID: 27126377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
